The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Open accessAbstract
In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding epithelial organoids that retain their tissue identity. We report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma (CRC) patients. For most, organoids were also generated from adjacent normal tissue. Organoids closely recapitulate several properties of the original tumor. The spectrum of genetic changes within the "living biobank" agrees well with previous large-scale mutational analyses of CRC. Gene expression analysis indicates that the major CRC molecular subtypes are represented. Tumor organoids are amenable to high-throughput drug screens allowing detection of gene-drug associations. As an example, a single organoid culture was exquisitely sensitive to Wnt secretion (porcupine) inhibitors and carried a mutation in the negative Wnt feedback regulator RNF43, rather than in APC. Organoid technology may fill the gap between cancer genetics and patient trials, complement cell-line- and xenograft-based drug studies, and allow personalized therapy design. PAPERCLIP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“‘living biobanks’ can provide access to patient-derived cells and organoids from large patient cohorts, and have already been established for different cancers124,151,176–178, genetic diseases such as cystic fibrosis, infectious diseases, chronic obstructive pulmonary disease and inflammatory bowel diseases179”
From Human disease models in drug development (2023) · cites this paper as [151]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Organoids are ideally suited for FPM due to their ease of establishment, similarity with the tissue of origin and tractability158,167 and have been deployed to identify therapeutic leads in a number of tumors168, including rare cancers that tend to be understudied and poorly characterized at the molecular level16,151,169,170.”
From Organoids (2022) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies using in vitro organoids grown from different intestinal tumors [33, 34] showed a strong correlation, functionally and molecularly with their primary tissue counterparts, providing a strong argument in favor of the potential for in vitro systems to model intestinal disease.”
From Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells (2018) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In short, the wild-type human colon organoid line P26n, as previously described in Van De Wetering et al. (2015) was cultured in domes of Cultrex Pathclear Reduced Growth Factor Basement Membrane Extract (BME) (3533-001; Amsbio).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as Van De Wetering et al. (2015)
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“broad clinical implementation of patient-specific disease models, such as PDOs, is currently hindered by low efficiencies in PDO establishment (60–70% success rate on average although, for some tissues, up to 90% have been reported for intestinal organoids151) as well as lengthy generation times and expansion procedures”
From Human disease models in drug development (2023) · cites this paper as [151]
The cited source says what the claim attributes to it.
In the citing paper
“Patient-derived tumor organoid (a.k.a. tumoroid) biobanks can be established from biopsies, surgical resections2,3, and even from Pap brushes4.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [3]
In the citing paper
“The reconstituted TME model recapitulates not only the genetic and phenotypic features of a tumor but also models the functional response of a patient to therapeutic agents [389, 390].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [389]
In the citing paper
“3D patient-derived tumor models of CRC (i.e., organoid and spheroid cultures) allow maintenance and expansion of functionally relevant cell subfractions and harbor the patients' individual genetic lesions (Ishiguro et al., 2017;van de Wetering et al., 2015).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as van de Wetering et al., 2015
In the citing paper
“Furthermore, with recent technological advancements (e.g. organoid models and conditionally reprogrammed cell lines), a new generation of cancer cell models is being derived to allow full representation of the histopathological and molecular diversity of tumours (37–42).”
From Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models (2019) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Self-citationA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Self-citationAdjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Self-citationVogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Self-citation
Flagged first, then by citations
1 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,001
A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity
Jung, D. J., Shin, T. H., Kim, M., Sung, C. O., Jang, S. J., & Jeong, G. S. (2019) · Lab on a Chip · doi:10.1039/c9lc00496c · Cited by 180
Zhou, Z., Cong, L., & Cong, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762184 · Cited by 189
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models
Lee, S., Koo, I.-S., Hwang, H. J., & Lee, D. W. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.03.006 · Cited by 193
Inflammation and Colorectal Cancer
Long, A., Lundsmith, E. T., & Hamilton, K. E. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0373-6 · Cited by 183
Patient-derived tumor organoids for prediction of cancer treatment response
Nagle, P. W., Plukker, J. T. M., Muijs, C. T., van Luijk, P., & Coppes, R. P. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.005 · Cited by 187
Booij, T. H., Price, L., & Danen, E. H. J. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219830087 · Cited by 180
Herpers, B., Eppink, B., James, M. I., Cortina, C., Cañellas-Socias, A., Boj, S. F., Hernando-Momblona, X., Glodzik, D., Roovers, R. C., van de Wetering, M., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00359-0 · Cited by 178
Self-citationthe Human Cell Atlas ‘Biological Network’ Organoids, Bock, C., Boutros, M., Camp, J. G., Clarke, L., Clevers, H., Knoblich, J. A., Liberali, P., Regev, A., Rios, A. C., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00762-x · Cited by 171
Self-citationTargeting TBK1 to overcome resistance to cancer immunotherapy
Sun, Y., Revach, O.-Y., Anderson, S., Kessler, E. A., Wolfe, C. H., Jenney, A., Mills, C. E., Robitschek, E. J., Davis, T. G. R., Kim, S., et al. (2023) · Nature · doi:10.1038/s41586-023-05704-6 · Cited by 174
α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer
Tran, T. Q., Hanse, E. A., Habowski, A. N., Li, H., Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Ooi, A. M., Liao, S. Y., Edwards, R. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0035-5 · Cited by 161
Hao, H.-X., Jiang, X., & Cong, F. (2016) · Cancers · doi:10.3390/cancers8060054 · Cited by 180
Tian, M., Wei, J., Lv, E., Li, C., Liu, G., Sun, Y., Yang, W., Wang, Q., Shen, C., Zhang, C., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155355 · Cited by 177
Hydrogel-based colorectal cancer organoid co-culture models
Luo, X., Fong, E. L. S., Zhu, C., Lin, Q. X. X., Xiong, M., Li, A., Li, T., Benoukraf, T., Yu, H., & Liu, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.037 · Cited by 177
Thorne, C. A., Chen, I. W., Sanman, L. E., Cobb, M. H., Wu, L. F., & Altschuler, S. J. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.01.024 · Cited by 174
Mouse models of colorectal cancer: Past, present and future perspectives
Bürtin, F., Mullins, C. S., & Linnebacher, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i13.1394 · Cited by 183
Human organoids: New strategies and methods for analyzing human development and disease
Corsini, N. S., & Knoblich, J. A. (2022) · Cell · doi:10.1016/j.cell.2022.06.051 · Cited by 176
Nanki, Y., Chiyoda, T., Hirasawa, A., Ookubo, A., Itoh, M., Ueno, M., Akahane, T., Kameyama, K., Yamagami, W., Kataoka, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69488-9 · Cited by 165
Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
Fujii, M., & Sato, T. (2020) · Nature Materials · doi:10.1038/s41563-020-0754-0 · Cited by 176
Efficient Use of Patient-Derived Organoids as a Preclinical Model for Gynecologic Tumors
Maru, Y., Tanaka, N., Itami, M., & Hippo, Y. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.05.005 · Cited by 162
Ex Vivo Tumor Culture Systems for Functional Drug Testing and Therapy Response Prediction
Meijer, T. G., Naipal, K. A. T., Jager, A., & van Gent, D. C. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0003 · Cited by 166
Patient-derived organoids in precision cancer medicine
Tong, L., Cui, W., Zhang, B., Fonseca, P., Zhao, Q. C., Zhang, P., Xu, B., Zhang, Q., Li, Z., Seashore-Ludlow, B. A., et al. (2024) · Med · doi:10.1016/j.medj.2024.08.010 · Cited by 192
Qu, J., Kalyani, F. S., Liu, L., Cheng, T., & Chen, L. (2021) · 癌症：英文版 · doi:10.1002/cac2.12224 · Cited by 173
Patient-derived induced pluripotent stem cells in cancer research and precision oncology
Papapetrou, E. P. (2016) · Nature Medicine · doi:10.1038/nm.4238 · Cited by 163
Grassi, L., Alfonsi, R., Francescangeli, F., Signore, M., Angelis, M. L. D., Addario, A., Costantini, M., Flex, E., Ciolfi, A., Pizzi, S., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1453-0 · Cited by 167
Xu, H., der Jeught, K. V., Zhou, Z., Zhang, L., Yu, T., Sun, Y., Li, Y., Wan, C., So, K. M., Liu, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146832 · Cited by 161
RetractedOrganoid cultures for cancer modeling
Yan, H. H. N., Chan, A., Lai, F. P.-L., & Leung, S. Y. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.012 · Cited by 176
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
Fessler, E., Drost, J., van Hooff, S. R., Linnekamp, J. F., Wang, X., Jansen, M., De Sousa E Melo, F., Prasetyanti, P. R., IJspeert, J. E., Franitza, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606184 · Cited by 159
Self-citationOverview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights
Farooqı, A. A., de la Roche, M., Djamgoz, M. B. A., & Siddik, Z. H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.01.001 · Cited by 158
Barrila, J., Crabbé, A., Yang, J., Franco, K., Nydam, S. D., Forsyth, R. J., Davis, R. R., Gangaraju, S., Ott, C. M., Coyne, C. B., et al. (2018) · Infection and Immunity · doi:10.1128/iai.00282-18 · Cited by 163
Heralding a new paradigm in 3D tumor modeling
Fong, E. L. S., Harrington, D. A., Farach‐Carson, M. C., & Yu, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.052 · Cited by 156
Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models
Kaushik, G., Ponnusamy, M. P., & Batra, S. K. (2018) · Stem Cells · doi:10.1002/stem.2852 · Cited by 156
Lallo, A., Frese, K. K., Morrow, C. J., Sloane, R. A. S., Gulati, S., Schenk, M. W., Trapani, F., Simms, N., Galvin, M., Brown, S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2805 · Cited by 156
Machine learning in the prediction of cancer therapy
Rafique, R., Islam, S. M. R., & Kazi, J. U. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.003 · Cited by 156
Modeling clear cell renal cell carcinoma and therapeutic implications
Wolf, M. M., Rathmell, W. K., & Beckermann, K. E. (2020) · Oncogene · doi:10.1038/s41388-020-1234-3 · Cited by 170
Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy
Denk, D., Petrocelli, V., Conche, C., Drachsler, M. W., Ziegler, P. K., Braun, A., Kress, A., Nicolas, A. M., Mohs, K., Becker, C., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.09.014 · Cited by 153
Cristobal, A., van den Toorn, H., van de Wetering, M., Clevers, H. C., Heck, A. J. R., & Mohammed, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.016 · Cited by 154
Self-citationHuman organoids: a new dimension in cell biology
Lehmann, R., Lee, C. M., Shugart, E. C., Benedetti, M., Charo, R. A., Gartner, Z. J., Hogan, B. L. M., Knoblich, J. A., Nelson, C. M., & Wilson, K. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-03-0135 · Cited by 158
Sun, H., Wang, H., Wang, X., Aoki, Y., Wang, X., Wang, Z., Cheng, X., Wang, Z., & Wang, X. (2020) · Theranostics · doi:10.7150/thno.43811 · Cited by 154
Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine
Gilazieva, Z., Ponomarev, A. S., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2020) · Cancers · doi:10.3390/cancers12102727 · Cited by 163
Next-Generation Surrogate Wnts Support Organoid Growth and Deconvolute Frizzled Pleiotropy In Vivo
Miao, Y., Ha, A., de Lau, W., Yuki, K., Santos, A. J. M., You, C., Geurts, M. H., Puschhof, J., Pleguezuelos-Manzano, C., Peng, W. C., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.07.020 · Cited by 151
Self-citationUnderstanding cell‐cell communication and signaling in the colorectal cancer microenvironment
AlMusawi, S., Ahmed, M., & Nateri, A. S. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.308 · Cited by 153
Bartfeld, S., & Clevers, H. C. (2015) · Journal of Visualized Experiments · doi:10.3791/53359 · Cited by 174
Self-citationKijima, T., Nakagawa, H., Shimonosono, M., Chandramouleeswaran, P. M., Hara, T., Sahu, V., Kasagi, Y., Kikuchi, O., Tanaka, K., Giroux, V., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.003 · Cited by 150
Gut organoids: mini-tissues in culture to study intestinal physiology and disease
Almeqdadi, M., Mana, M., Roper, J., & Yilmaz, Ö. H. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00300.2017 · Cited by 160
DNA damage induces p53-independent apoptosis through ribosome stalling
Boon, N. J., Oliveira, R. A., Körner, P.-R., Kochavi, A., Mertens, S., Malka, Y., Voogd, R., van der Horst, S. E. M., Huismans, M. A., Smabers, L. P., et al. (2024) · Science · doi:10.1126/science.adh7950 · Cited by 161
Self-citationMex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy
Álvarez-Varela, A., Novellasdemunt, L., Barriga, F. M., Hernando‐Momblona, X., Cañellas-Socias, A., Cano-Crespo, S., Sevillano, M., Cortina, C., Stork, D., Morral, C., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00402-0 · Cited by 153
Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids
Mao, Y., Wang, W., Yang, J., Zhou, X., Lu, Y., Gao, J., Wang, X., Wen, L., Fu, W., & Tang, F. (2023) · Protein & Cell · doi:10.1093/procel/pwad038 · Cited by 155
Theranostic barcoded nanoparticles for personalized cancer medicine
Yaari, Z. A., da Silva, D., Zinger, A., Goldman, E., Kajal, A., Tshuva, R., Barak, E., Dahan, N., Hershkovitz, D., Goldfeder, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13325 · Cited by 147
Praharaj, P. P., Bhutia, S. K., Nagrath, S., Bitting, R. L., & Deep, G. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.005 · Cited by 152
Li, N., Babaei‐Jadidi, R., Lorenzi, F., Spencer‐Dene, B., Clarke, P. A., Domingo, E., Tulchinsky, E. M., Vries, R. G. J., Kerr, D. J., Pan, Y., et al. (2019) · Oncogenesis · doi:10.1038/s41389-019-0125-3 · Cited by 146
Self-citationCharacterizing the ecological and evolutionary dynamics of cancer
Zahir, N., Sun, R., Gallahan, D., Gatenby, R. A., & Curtis, C. N. (2020) · Nature Genetics · doi:10.1038/s41588-020-0668-4 · Cited by 144
Ponsioen, B., Post, J. B., Amorie, J. R. B. D., Laskaris, D., van Ineveld, R. L., Kersten, S., Bertotti, A., Sassi, F. P., Sipieter, F., Cappe, B., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00654-5 · Cited by 148
Self-citationProspective experimental treatment of colorectal cancer patients based on organoid drug responses
Ooft, S., Weeber, F., Schipper, L. J., Dijkstra, K. K., McLean, C. M., Kaing, S., van de Haar, J., Prevoo, W., van Werkhoven, E. D., Snæbjörnsson, P., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100103 · Cited by 150
Organoids in gastrointestinal diseases: From experimental models to clinical translation
Günther, C., Winner, B., Neurath, M. F., & Stappenbeck, T. S. (2022) · Gut · doi:10.1136/gutjnl-2021-326560 · Cited by 145
Boehnke, K., Iversen, P. W., Schumacher, D., Lallena, M. J., Haro, R., Amat, J., Haybaeck, J., Liebs, S., Lange, M., Schäfer, R., et al. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116650965 · Cited by 145
Newey, A., Griffiths, B. L., Michaux, J., Pak, H. S., Stevenson, B. J., Woolston, A., Semiannikova, M., Spain, G., Barber, L. J., Matthews, N., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0769-8 · Cited by 133
3D Cell Cultures: Evolution of an Ancient Tool for New Applications
Cacciamali, A., Villa, R., & Dotti, S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.836480 · Cited by 166
Human Cardiac Organoids for Disease Modeling
Nugraha, B., Buono, M. F., von Boehmer, L., Hoerstrup, S. P., & Emmert, M. Y. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1286 · Cited by 149
Patient-Derived Organoids for Precision Cancer Immunotherapy
Grönholm, M., Feodoroff, M., Antignani, G., Martins, B., Hamdan, F., & Cerullo, V. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4026 · Cited by 146
Intestinal epithelial organoids fuse to form self-organizing tubes in floating collagen gels
Sachs, N., Tsukamoto, Y., Kujala, P., Peters, P. J., & Clevers, H. C. (2017) · Development · doi:10.1242/dev.143933 · Cited by 144
Self-citationMouse models of intestinal cancer
Jackstadt, R., & Sansom, O. J. (2015) · The Journal of Pathology · doi:10.1002/path.4645 · Cited by 147
Translational applications of adult stem cell-derived organoids
Drost, J., & Clevers, H. C. (2017) · Development · doi:10.1242/dev.140566 · Cited by 144
Self-citationModeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids
Fujii, M., Clevers, H. C., & Sato, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.048 · Cited by 146
Self-citationOrganoid based personalized medicine: from bench to bedside
Li, Y., Tang, P., Cai, S., Peng, J., & Hua, G. (2020) · Cell Regeneration · doi:10.1186/s13619-020-00059-z · Cited by 149
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Liu, L., Yu, L., Li, Z., Li, W., & Huang, W. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02677-2 · Cited by 145
Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids
Geurts, M. H., de Poel, E., Pleguezuelos-Manzano, C., Oka, R., Carrillo, L., Andersson-Rolf, A., Boretto, M., Brunsveld, J. E., van Boxtel, R., Beekman, J. M., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000940 · Cited by 151
Self-citationKidney Organoids: A Translational Journey
Morizane, R., & Bonventre, J. V. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.001 · Cited by 138
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
Liu, S. J., Malatesta, M., Lien, B. V., Saha, P., Thombare, S. S., Hong, S. J., Pedraza, L., Koontz, M., Seo, K., Horlbeck, M. A., et al. (2020) · Genome biology · doi:10.1186/s13059-020-01995-4 · Cited by 144
Finnberg, N. K., Gokare, P. R., Lev, A., Grivennikov, S. I., Macfarlane, A. W., Campbell, K. S., Winters, R. M., Kaputa, K., Farma, J. M., Abbas, A. E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19965 · Cited by 144
Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
Li, Z., Qian, Y., Li, W., Liu, L., Yu, L., Liu, X., Wu, G., Wang, Y., Luo, W., Fang, F., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101411 · Cited by 136
Patient-derived organoid models help define personalized management of gastrointestinal cancer
Aberle, M. R., Burkhart, R. A., Tiriac, H., Damink, S. W. M. O., Dejong, C. H. C., Tuveson, D. A., & van Dam, R. M. (2018) · British journal of surgery · doi:10.1002/bjs.10726 · Cited by 141
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
Prince, E., Cruickshank, J., Ba-Alawi, W., Hodgson, K., Haight, J., Tobin, C., Wakeman, A., Avoulov, A., Topolskaia, V., Elliott, M. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28788-6 · Cited by 135
Primary Cell-Derived Intestinal Models: Recapitulating Physiology
Dutton, J. S., Hinman, S. S., Kim, R., Wang, Y., & Allbritton, N. L. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.12.001 · Cited by 141
Mulholland, T., McAllister, M. J., Patek, S., Flint, D., Underwood, M., Sim, A., Edwards, J., & Zagnoni, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33055-0 · Cited by 132
Barnes, B. M., Nelson, L., Tighe, A., Burghel, G. J., Lin, I., Desai, S. N., McGrail, J. C., Morgan, R. D., & Taylor, S. S. (2021) · Genome Medicine · doi:10.1186/s13073-021-00952-5 · Cited by 140
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Helou, R. E., Pinna, G., Cabaud, O., Wicinski, J., Bhajun, R., Guyon, L., Rioualen, C., Finetti, P., Gros, A., Mari, B. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.016 · Cited by 136
Current Screening Methodologies in Drug Discovery for Selected Human Diseases
Lage, O. M., Ramos, M. C., Calisto, R., Almeida, E., Vasconcelos, V. M., & Vicente, F. (2018) · Marine Drugs · doi:10.3390/md16080279 · Cited by 139
Cell-type-specific signaling networks in heterocellular organoids
Qin, X., Sufi, J., Vlckova, P., Kyriakidou, P., Acton, S. E., Li, V. S. W., Nitz, M., & Tape, C. J. (2020) · Nature Methods · doi:10.1038/s41592-020-0737-8 · Cited by 134
Self-citationNext generation organoids for biomedical research and applications
Lou, Y., & Leung, A. W. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.10.005 · Cited by 138
Regan, J. L., Schumacher, D., Staudte, S., Steffen, A., Haybaeck, J., Keilholz, U., Schweiger, C., Golob‐Schwarzl, N., Mumberg, D., Henderson, D. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.025 · Cited by 131
Decarli, M. C., do Amaral, R. L. F., dos Santos, D. P., Tofani, L. B., Katayama, E. T., Rezende, R. A., da Silva, J. V. L., Swiech, K., Suazo, C. A. T., Mota, C., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abe6f2 · Cited by 138
Exploring the human lacrimal gland using organoids and single-cell sequencing
Bannier-Hélaouët, M., Post, Y., Korving, J., Bustos, M. T., Gehart, H., Begthel, H., Bar‐Ephraïm, Y. E., van der Vaart, J., Kalmann, R., Imhoff, S. M., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.024 · Cited by 134
Self-citationHarane, S. E., Zidi, B., Harane, N. E., Krause, K., Matthes, T., & Preynat‐Seauve, O. (2023) · Cells · doi:10.3390/cells12071001 · Cited by 135
Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics
Haseeb, M., Pirzada, R. H., Ain, Q. U., & Choi, S. (2019) · Cells · doi:10.3390/cells8111380 · Cited by 136
Organoids as host models for infection biology – a review of methods
Aguilar, C., da Silva, M. A., Saraiva, M., Neyazi, M., Olsson, I. A. S., & Bartfeld, S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00629-4 · Cited by 131
Self-citationPatient-Derived Cancer Organoids as Predictors of Treatment Response
Verduin, M., Hoeben, A., Ruysscher, D. D., & Vooijs, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641980 · Cited by 140
Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening
Du, Y., Li, X., Niu, Q., Mo, X., Qui, M., Ma, T., Kuo, C. J., & Fu, H. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa036 · Cited by 125
High-throughput imaging: Focusing in on drug discovery in 3D
Li, L., Zhou, Q., Voss, T. C., Quick, K. L., & LaBarbera, D. V. (2015) · Methods · doi:10.1016/j.ymeth.2015.11.013 · Cited by 131
Yang, C. Q., Xia, B.-R., Jin, W., & Lou, G. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1067-8 · Cited by 135
Zheng, H., Liu, J., Cheng, Q., Zhang, Q., Zhang, Y., Jiang, L., Huang, Y., Li, W., Zhao, Y., Chen, G., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00715-8 · Cited by 134
RetractedApplications of tumor chip technology
Hachey, S. J., & Hughes, C. C. W. (2018) · Lab on a Chip · doi:10.1039/c8lc00330k · Cited by 128
Senkowski, W., Gall-Mas, L., Falco, M. M., Li, Y., Lavikka, K., Kriegbaum, M. C., Oikkonen, J., Bulanova, D. R., Pietras, E. J., Voßgröne, K., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.04.012 · Cited by 128
Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models
Huang, Y., Huang, Z., Tang, Z., Chen, Y., Huang, M., Liu, H., Huang, W., Ye, Q., & Jia, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740574 · Cited by 134
High‐throughput screening in colorectal cancer tissue‐originated spheroids
Kondo, J., Ekawa, T., Endo, H., Yamazaki, K., Tanaka, N., Kukita, Y., Okuyama, H., Okami, J., Imamura, F., Ohue, M., et al. (2018) · Cancer Science · doi:10.1111/cas.13843 · Cited by 123
Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles
Yan, H. H. N., Siu, H. C., Ho, S. L., Yue, S. S. K., Gao, Y., Tsui, W. Y., Chan, D., Chan, A., Wong, J. W. H., Man, A. H. Y., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320019 · Cited by 127
Self-citationDerivation of a robust mouse mammary organoid system for studying tissue dynamics
Jamieson, P. R., Dekkers, J. F., Rios, A. C., Fu, N. Y., Lindeman, G. J., & Visvader, J. E. (2016) · Development · doi:10.1242/dev.145045 · Cited by 128
Lõhmussaar, K., Kopper, O., Korving, J., Begthel, H., Vreuls, C. P. H., van Es, J. H., & Clevers, H. C. (2020) · Nature Communications · doi:10.1038/s41467-020-16432-0 · Cited by 126
Self-citationA genome editing approach to study cancer stem cells in human tumors
Cortina, C., Turón, G., Stork, D., Hernando‐Momblona, X., Sevillano, M., Aguilera, M., Tosi, S., Merlos‐Suárez, A., Attolini, C. S., Sancho, E., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707550 · Cited by 124
Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1
Chen, S., Cui, W., Chi, Z., Xiao, Q., Hu, T., Ye, Q., Zhu, K., Yu, W., Wang, Z., Yu, C., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.016 · Cited by 123
Cancer research using organoid technology
Kretzschmar, K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01990-z · Cited by 120
Metadata
- Authors
- van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., McLaren-Douglas, A., Blokker, J., Jaksani, S., Bartfeld, S., Volckman, R., van Sluis, P., Li, V. S. W., Seepo, S., Sekhar Pedamallu, C., Cibulskis, K., Carter, S. L., McKenna, A., Lawrence, M. S., Lichtenstein, L., Stewart, C., Koster, J., Versteeg, R., van Oudenaarden, A., Saez-Rodriguez, J., Vries, R. G. J., Getz, G., Wessels, L., Stratton, M. R., McDermott, U., Meyerson, M., Garnett, M. J., & Clevers, H.
- Affiliations
- Wellcome Sanger Institute (GB)
- Broad Institute (US)
- The Netherlands Cancer Institute (NL)
- European Bioinformatics Institute (GB)
- Diakonessenhuis hospital (NL)
- Royal Netherlands Academy of Arts and Sciences (NL)
- National Institute for Medical Research (GB)
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Garnett, Mathew J.
- Clevers, Hans
- ORCID
- Francis, Joshua M.
- Iorio, Francesco
- Pronk, Apollo
- Taylor-Weiner, Amaro
- Kester, Lennart
- Bartfeld, Sina
- Li, Vivian S.W.
- Cibulskis, Kristian
- Carter, Scott L.
- McKenna, Aaron
- Lawrence, Michael S.
- Stewart, Chip
- Versteeg, Rogier
- Vries, Robert G.J.
- Getz, Gad
- Wessels, Lodewyk
- Stratton, Michael R.
- McDermott, Ultan
- Meyerson, Matthew
- Garnett, Mathew J.
- Clevers, Hans
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 161
- Issue
- 4
- Pages
- 933-945
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6428276
- OpenAlex
- W1741548448
- Cited by
- 2,408
- References
- 64
- Citations by year
- 2026: 196 · 2025: 233 · 2024: 232 · 2023: 220 · 2022: 267 · 2021: 343 · 2020: 260 · 2019: 181 · 2018: 173 · 2017: 154 · 2016: 108 · 2015: 39
- FWCI
- 69.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- Francis Crick Institute (10105)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- colorectal cancer, tumor organoids, organoid biobank, Lgr5+ stem cells, R-spondin, Wnt signaling, porcupine inhibitor, RNF43 mutation, APC mutation, drug screening, personalized treatment, molecular subtypes, gene expression profiling
- MeSH terms
- DNA-Binding Proteins, Drug Screening Assays, Antitumor, Humans, Organ Culture Techniques, Organoids, Colorectal Neoplasms, Oncogene Proteins, Biological Specimen Banks, Ubiquitin-Protein Ligases, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
